Sanofi Winthrop Industrie
39 products tracked · names used in filings: Sanofi Winthrop Industrie
Upcoming milestones
VaxRabeo (rabies vaccine (inactivated) for human): expected EC decision
Estimated as CHMP opinion (2026-09-17) + 67 days, the standard Commission decision period. Not an official date. · Sanofi Winthrop Industrie · source
Recent milestones
VaxRabeo (rabies vaccine (inactivated) for human): CHMP positive opinion
Cenrifki (tolebrutinib) approved in the EU
Marketing authorisation to Sanofi Winthrop Industrie; Additional monitoring · source
Cenrifki (tolebrutinib): CHMP positive opinion
Sanofi Winthrop Industrie; Additional monitoring · source
Supemtek (trivalent influenza vaccine (recombinant, prepared in cell culture)) approved in the EU
Marketing authorisation to Sanofi Winthrop Industrie · source
Rezurock (belumosudil) approved in the EU
Marketing authorisation to Sanofi Winthrop Industrie; Orphan, Conditional, Additional monitoring · source
Supemtek (trivalent influenza vaccine (recombinant, prepared in cell culture)): CHMP positive opinion
Rezurock (belumosudil): CHMP positive opinion
Sanofi Winthrop Industrie; Orphan, Conditional, Additional monitoring · source
Teizeild (teplizumab) approved in the EU
Marketing authorisation to Sanofi Winthrop Industrie; PRIME, Additional monitoring · source
Teizeild (teplizumab): CHMP positive opinion
Sanofi Winthrop Industrie; PRIME, Additional monitoring · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | VaxRabeo rabies vaccine (inactivated) for human | Opinion | |
| 🇪🇺 | Cenrifki tolebrutinib | Authorised | 2026-06-19 |
| 🇪🇺 | Supemtek trivalent influenza vaccine (recombinant, prepared in cell culture) | Authorised | 2026-03-30 |
| 🇪🇺 | Rezurock belumosudil | Authorised | 2026-03-24 |
| 🇪🇺 | Teizeild teplizumab | Authorised | 2026-01-08 |
| 🇪🇺 | Beyfortus nirsevimab | Authorised | 2022-10-31 |
| 🇪🇺 | Truvelog Mix 30 insulin aspart | Withdrawn | 2022-04-25 |
| 🇪🇺 | Nuvaxovid COVID-19 Vaccine (recombinant, adjuvanted) | Authorised | 2021-12-20 |
| 🇪🇺 | MenQuadfi meningococcal group A, C, W-135 and Y conjugate vaccine | Authorised | 2020-11-18 |
| 🇪🇺 | Supemtek Tetra (previously Supemtek) quadrivalent influenza vaccine (recombinant, prepared in cell culture) | Authorised | 2020-11-16 |
| 🇪🇺 | Insulin aspart Sanofi insulin aspart | Authorised | 2020-06-25 |
| 🇪🇺 | Sarclisa isatuximab | Authorised | 2020-05-30 |
| 🇪🇺 | Dengvaxia dengue tetravalent vaccine (live, attenuated) | Withdrawn | 2018-12-12 |
| 🇪🇺 | Dupixent dupilumab | Authorised | 2017-09-26 |
| 🇪🇺 | Insulin lispro Sanofi insulin lispro | Authorised | 2017-07-19 |
| 🇪🇺 | Kevzara sarilumab | Authorised | 2017-06-23 |
| 🇪🇺 | Suliqua insulin glargine;lixisenatide | Authorised | 2017-01-11 |
| 🇪🇺 | Praluent alirocumab | Authorised | 2015-09-23 |
| 🇪🇺 | Sevelamer carbonate Winthrop (previously Sevelamer carbonate Zentiva) sevelamer carbonate | Authorised | 2015-01-15 |
| 🇪🇺 | Aubagio teriflunomide | Authorised | 2013-08-26 |
| 🇪🇺 | Hexacima diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed) | Authorised | 2013-04-17 |
| 🇪🇺 | Hexyon diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed) | Authorised | 2013-04-17 |
| 🇪🇺 | Zaltrap aflibercept | Authorised | 2013-02-01 |
| 🇪🇺 | Lyxumia lixisenatide | Withdrawn | 2013-01-31 |
| 🇪🇺 | Jevtana cabazitaxel | Authorised | 2011-03-17 |
| 🇪🇺 | DuoPlavin clopidogrel;acetylsalicylic acid | Authorised | 2010-03-14 |
| 🇪🇺 | Multaq dronedarone | Authorised | 2009-11-25 |
| 🇪🇺 | Renvela sevelamer carbonate | Authorised | 2009-06-09 |
| 🇪🇺 | Fasturtec rasburicase | Authorised | 2001-02-23 |
| 🇪🇺 | Thyrogen thyrotropin alfa | Authorised | 2000-03-09 |
| 🇪🇺 | Renagel sevelamer | Authorised | 2000-01-28 |
| 🇪🇺 | Karvezide irbesartan;hydrochlorothiazide | Authorised | 1998-10-16 |
| 🇪🇺 | CoAprovel irbesartan;hydrochlorothiazide | Authorised | 1998-10-14 |
| 🇪🇺 | Plavix clopidogrel | Authorised | 1998-07-15 |
| 🇪🇺 | Iscover clopidogrel | Authorised | 1998-07-14 |
| 🇪🇺 | Aprovel irbesartan | Authorised | 1997-08-26 |
| 🇪🇺 | Karvea irbesartan | Authorised | 1997-08-26 |
| 🇪🇺 | Rilutek riluzole | Authorised | 1996-06-10 |
| 🇪🇺 | Taxotere docetaxel | Authorised | 1995-11-27 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.